Our specialties
Exams & training

Member benefits

View

Recent changes to the CR2B

The FRCR Part 2B (CR2B) examination has undergone several important changes to ensure the assessment remains robust, fair, and reflective of current clinical practice.
LEARN MORE

Background

The changes were implemented from June 2025 to align the exam with current practice  GMC standards for assessment. This aims to ensure the exam continues to be a fair and robust assessment of the knowledge and skills required across the curriculum at the expected level of competence. 
Some core elements of the exam remain the same:

  • The CR2B exam consists of three components; an Oral component and two reporting components.
  • All components are taken at the same sitting.
  • The type and level of content included in the exam remains unchanged.

Oral component

The Oral component continues to be delivered across two sessions, each lasting  30 minutes and each with a pair of examiners presenting cases to the candidates. Candidates are still required to attend an exam venue and the Oral will be delivered via video link with the examiners. 

Examiners present cases using a range of imaging modalities. Candidates will have the ability to manipulate and scroll through images. 

The level and type of content used within the Oral component remains the same.

A logical and informed approach to image interpretation, as well as a clear ability to debate the merits, relevance and role of techniques that might assist in further investigation of diagnostic problems, are expected. Examiners may ask supplementary questions to further assess a candidate’s understanding of the problem. 

The following changes have been introduced: 

  • Changes to the system of scoring with the use of a domain-based marking approach and a new standard setting methodology. 
  • Increased standardisation of the exam. There is a central bank of Oral cases and candidates will be presented with a set of cases that have been quality reviewed. The set of cases will be balanced across the syllabus and for difficulty. All candidates will encounter the same number of cases (six cases per Oral session, 12 cases in total)
  • Candidates can expect cases of varying difficulty (some being expected to be relatively easy and some harder). This is accounted for in marking and standard setting.
  • All candidates being examined on the same day will be presented with the same set of cases. To support this, candidate quarantine has been introduced. This means a period of waiting before/after the Oral sessions in a designated waiting area. Arrival and departure times will be indicated to candidates on their timetables. This step is important to ensure that the exam security is maintained 
  • The delivery of the exam has moved to the Risr/Assess platform. This platform supports the video link between examiners and candidates and the sharing of cases with the candidate. This is the same platform used for the CR2B reporting components
The scoring system in detail

Reporting components

The two separate reporting components continue to be delivered on the same day. Candidates are still required to attend an exam venue and both components are delivered via the risr/Assess platform. 

Across the reporting components, there are no fixed criteria for coverage of specific pathology, but content will be appropriately balanced and representative. The cases may vary in complexity and difficulty – this will be accounted for in standard setting.

Long case reporting

There has been no change to the format, exam structure, or content of this component. It continues to be six cases, each of which requires a report. Each case may comprise multiple modalities and sequences. Brief case histories and other relevant clinical data for each case are provided.

Candidates responses are recorded in a standard format: 

  • Observations: observations from all the imaging studies available, including relevant positive and negative findings. 
  • Interpretation: interpretations of the observed findings; for example, describing whether the mass or process observed is benign, malignant or infective rather than neoplastic, giving reasons. 
  • Main or Principal Diagnosis: A single diagnosis based on the interpretations. If a single diagnosis is not possible, then the most likely diagnosis should be stated. 
  • Any Differential Diagnoses: For some cases there will be no differential diagnoses; in others a few may merit inclusion. These should be limited in number and brief, and the report should indicate why these were less likely than the main or principal diagnosis above. 
  • Any Relevant Further Investigations or Management: Any further appropriate investigations or clinical management.

The following has been introduced: 

  • Changes to the scoring system and standard setting
The scoring system in detail

Short case reporting

This new assessment replaces the old rapid reporting component. This current component does not represent a fundamental change in what is assessed i.e. it remains primarily intended to assess interpretation of plain radiographs. The current question format will allow for more complex imaging to be used – but still appropriate to the level of the exam. The format is as follows:

  • A short answer question type. Candidates will be presented with a case which will include a brief clinical history and plain radiograph. Candidates will be asked to write a short report and include their next recommended management step for the patient. 
  • There will be 25 questions in the component, and a two-hour duration.
  • A scoring system to align with the question format and use of standard setting is used.
  • The component will not include cases where the images would be considered as ‘normal’.

The coverage of chest, musculoskeletal and abdominal X-rays falls approximately within the ranges indicated below:

  • CXR: 50-60% of the set
  • MSK: 40-50% of the set
  • AXR: up to 4% (1 question) of the set

The coverage of adult and paediatric cases is split as indicated below:

  • Adult cases: approximately 75%
  • Paediatric cases: approximately 25%

Short case reporting sample questions

Sample short cases and sample answers are provided below to give guidance on the difference between high scoring, medium scoring and low scoring answers. Short, simple statements of your observations, diagnosis and recommendation are all that is needed. You do not need to write full sentences. 

The examiner marking guidance shown next to the sample answers is intended to give context on the marking of each case. The examiner marking guidance indicates key findings, diagnosis and recommended onward management. There is also brief commentary next to the sample answers to explain why the specific answer may score in that way.  Examiners will use the mark scheme descriptors (as detailed in the scoring system) alongside this marking guidance to score candidates’ responses and each case will be awarded a score of 0 – 5. There is no concept of a pass or fail per case as all cases are standard set as to their difficulty. The modified Angoff process is used to determine the pass mark for each sitting based on the content used.  

We suggest that before reviewing the resources below, candidates preparing for the exam review the content in the risr/assess demonstration site. The demonstration site includes the same content but the images will be optimised for viewing and provide better examples of the image quality in the exam. 

Please note that the examiner marking guidance will not be available to candidates as part of their results/feedback. 

Learn more about the scoring system

CR2B pass/fail decisions

The overall CR2B structure has been maintained whereby all components are taken at the same sitting. However, there has been an adjusted method of calculation to identify pass/fails. 

For further information see the scoring system information page

Learn more about the scoring system

Introduction to changes to the FRCR 2B Exam

Video simulation of the Oral component

A role-played encounter between examiners and candidate for the FRCR Part 2B (CR2B) oral component. 

FAQs